Validation of the Molecular International Prognostic Scoring System (IPSS-M) in Patients (Pts) with Myelodysplastic Syndromes/Neoplasms (MDS) Who Were Treated with Hypomethylating Agents (HMA)Tariq Kewan, Amer M. Zeidan, Ondřej Bláha et al.|Blood|2023Cited by 0